Abstract | OBJECTIVES: The aims of this study were to measure levels of colony stimulating factor (CSF-1) in patients with trophoblastic disease, to determine whether such measurement may be useful to supplement measurement of the prognostically reliable human chorionic gonadotrophin (hCG), and to assess whether measurement of CSF-1 may be helpful in predicting requirement for chemotherapy in patients with hydatidiform mole. METHODS: RESULTS: In this study of 45 patients with trophoblastic disease, some very high levels of CSF-1 were encountered. In a few patients there was dramatic correlation with hCG. Generally, however, CSF-1 and hCG did not correlate. CSF-1 was frequently not elevated when hCG was still significantly elevated and conversely CSF-1 was elevated when hCG was negative. CONCLUSION: The measurement of CSF-1 does not appear to be useful in managing trophoblastic disease as it does not correlate with the level of hCG. Occasionally, high levels of CSF-1 were found in patients with trophoblastic disease.
|
Authors | E I Kohorn, B M Kacinski, E R Stanley |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 80
Issue 3
Pg. 383-6
(Mar 2001)
ISSN: 0090-8258 [Print] United States |
PMID | 11263936
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Copyright | Copyright 2001 Academic Press. |
Chemical References |
- Chorionic Gonadotropin
- Macrophage Colony-Stimulating Factor
|
Topics |
- Adolescent
- Adult
- Aged
- Chorionic Gonadotropin
(blood)
- Female
- Humans
- Hydatidiform Mole
(blood, drug therapy)
- Macrophage Colony-Stimulating Factor
(blood)
- Male
- Middle Aged
- Predictive Value of Tests
- Pregnancy
- Radioimmunoassay
- Risk Factors
- Trophoblastic Neoplasms
(blood)
- Uterine Neoplasms
(blood)
|